## Background: Mutations of p53 can lead to the production of anti-p53 antibodies in sera of cancer patients. before this study, the value of preoperative serum anti-p53 antibodies in determining the prognoses of patients with gastric carcinoma had yet to be determined. ## Methods: The authors us
Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients
β Scribed by Navapun Charuruks; Pisit Tangkijvanich; Narin Voravud; Ratana Chatsantikul; Apiradee Theamboonlers; Yong Poovorawan
- Publisher
- Springer Japan
- Year
- 2001
- Tongue
- English
- Weight
- 78 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To clarify the clinical significance of the mutation of p53 gene in hepatocellular carcinoma (HCC), 90 resected specimens from Japanese patients were assayed using a polymerase chain reaction-single strand conformation polymorphism (PCRSSCP) analysis. p53 mutations were detected in 25 cases (27.8%)
## BACKGROUND. Alterations in the expression of p53 tumor suppressor protein is a frequent event in human cancer but the practical implications of this phenomenon are yet to be fully exploited. The objective of this study was to determine the value of p53 accumulation as a marker of tumor progress
## Abstract This study examined the sensitivity and specificity of serum autoβantibodies to p53 protein as a nonβinvasive marker of p53 genetic alterations or protein accumulation in lung cancer cases. A sensitive ELISA to detect serum p53 antibodies was developed and used to examine sera from 186